Yuva Biosciences
Birmingham, US · Founded 2019 · Delaware corporation · 5 known investors
Proprietary platform developing products to improve mitochondrial health.
Founders & leadership
GS
Greg SchmergelExecutive
Board
FE
Fred EhrsamBoard director
DB
Daniel BrowneBoard director
Investors · 5
Western Technology InvestmentPortola Valley · $250K – $30M
TBD AngelsreportedNew York
VentureSouthreported · 2 sourcesGreenville
Also in the syndicate · 2
Atma CapitalLongevity Tech Fund
Reported raises · per SEC filings
Form D private placements$1.1M disclosed across 1 of 2 rounds · 2023–2026
▶$1.1MraisedMar 2026 · 11 investors · OtherRule 506(b)
▶$1.1MraisedMar 2026 · 11 investors · Other
Rule 506(b)Officers, directors & promoters on the filing
- Greg SchmergelExecutive Officer, Director
- Fred EhrsamDirector
- Daniel BrowneDirector
- Offering amount
- $3M
- Amount sold
- $1.1M
- First sale
- Mar 2026
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$4.5MofferedNov 2023 · OtherRule 506(b)
▶$4.5MofferedNov 2023 · Other
Rule 506(b)Officers, directors & promoters on the filing
- Greg SchmergelExecutive Officer, Director
- Offering amount
- $4.5M
- Incorporated
- Corporation, Delaware, 2019
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
In the news
Frequently asked questions
- What does Yuva Biosciences do?
- Proprietary platform developing products to improve mitochondrial health.
- Who are Yuva Biosciences's investors?
- Yuva Biosciences's investors include Western Technology Investment, TBD Angels, VentureSouth.
- How much funding has Yuva Biosciences raised?
- Yuva Biosciences has disclosed $1.1M raised across 1 of its 2 known rounds.
- Where is Yuva Biosciences headquartered?
- Yuva Biosciences is headquartered in Birmingham, US.